News in brief: Key Neurotech phase III trial underway; London dates confirmed for Cannabis Europa; Vitura sets AGM date by Steve Jones September 22, 2026September 24, 2026 Drug development firm Neurotech International (NTI) has dosed the first patient in its pivotal phase III […]
Neurotech shares jump 25% as chairman speaks of ‘considerable opportunity’ by Steve Jones August 27, 2026August 27, 2026
News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial by Adam Sheldon March 17, 2026June 8, 2026
Family experience of MC drives Medibis to fund autism anxiety trial by Adam Sheldon August 5, 2025August 19, 2025
Medibis embarks on fresh capital raise ahead of autism clinical trial by Steve Jones February 23, 2024February 28, 2024
